State of New Jersey Common Pension Fund D’s Prime Medicine PRME Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$107K	Buy	+30,845	New	+$117K	﹤0.01%	1547

Other funds holding PRME

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State of New Jersey Common Pension Fund D's PRME Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Prime Medicine (PRME) in Q1 2026: 30,845 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #1547 among its holdings.

192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

State of New Jersey Common Pension Fund D held 30,845 shares of Prime Medicine worth $107K as of Q1 2026.
Prime Medicine was a new State of New Jersey Common Pension Fund D position in Q1 2026.
Prime Medicine made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #1547 holding.
192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.